Incidence and clinical presentation of posttransfusion TT virus infection in prospectively followed transfusion recipients: emphasis on its relevanceto hepatitis
Jt. Wang et al., Incidence and clinical presentation of posttransfusion TT virus infection in prospectively followed transfusion recipients: emphasis on its relevanceto hepatitis, TRANSFUSION, 40(5), 2000, pp. 596-601
BACKGROUND: A novel transfusion-transmissible human DNA virus, TT virus (TT
V), has been discovered recently. An attempt was made to determine the inci
dence and clinical outcome of TTV infection in recipients of blood transfus
ion.
STUDY DESIGN AND METHODS: Serial serum samples collected as part of a prosp
ective study of posttransfusion hepatitis were examined for TTV DNA by a ne
sted PCR assay.
RESULTS: Among 150 adults undergoing cardiac surgery, posttransfusion speci
mens from 59 individuals were positive for rn! DNA. Pretransfusion sera wer
e found to be positive in 13 of these individuals. Therefore, 46 (33.6%) of
the 137 previously uninfected patients developed new TTV viremia after tra
nsfusion. Among the 46 patients, 3 were coinfected with HCV, 5 were coinfec
ted with HGV, and 38 were infected with TTV alone. No apparent symptoms or
signs were noted in the 38 patients infected by TTV alone or the 5 infected
with HGV plus TTV. The average peak serum ALT activity was 31 IU per L, wi
th persistently normal levels in 34 of the 38 patients with TTV infection a
lone. In 8 other patients who subsequently developed well-documented non-A-
G hepatitis, 3 were positive for TTV (3/8 vs. 46/137, p = 0.8). In 12 patie
nts followed for more than 1 year, TTV viremia persisted in every case.
CONCLUSION: In this population, TTV is transmitted by transfusion to approx
imately 30 percent of patients who undergo cardiac surgery. Most of the inf
ections appear to become persistent. Despite the high prevalence rate, TTV
does not appear to cause hepatitis on its own.